Clay Seagull describes life in a funny way. According to a recent interview, he did with ideamensch; Clay describes how he saw things at different stages in his life. During his twenties, he thought he knew everything, during his thirties, he realized that there was much he was yet to learn, now in his forties, Clay says that he has finally confirmed that he doesn’t know much. Clay B. Seagull, the man who co-founded Seattle Genetics back in the year 1998, has achieved so much in his life. He is both the Chief Executive Officer and president of Seattle. Besides this, he is also the chairman of the company’s board.
Clay is a trained scientist whose training is centered on cancer therapies. His love for science was what drove him to create Seattle Genetics, which deals with the provision of various treatment services. During that time, he yearned to create a platform where it would be possible to carry out rigorous and effective research and still be in a position to create effective drugs from the research. All these things would, in turn, achieve one thing which was to help patients from different backgrounds find a cure for the different diseases that they were suffering from.
Since the founding of the company, Siegall has been guiding Seattle from the frontline over the years. Today, Seattle is among the top companies when it comes to the development of antibody-drug conjugates, which are commonly referred to as ADCs. In 2011, the company received FDA approval for their first antibody-drug conjugate product, which they called ADCETRIS. Since the approval, Seattle has been working with Takeda Pharmaceutical Company to advertise and sell the drug. ADCETRIS is now enjoying a global market. It has been approved and is being sold in 65 countries at the moment.
Before Siegall thought of creating Seattle Genetics, he worked at the Bristol-Myers Squibb Pharmaceutical Research Institute. He worked here between 1991 and 1997. He also worked at the National Institute of Health and at the National Cancer Institute after that. Dr. Siegall targets to achieve an effective and efficient cure for cancer through his organization, and one can tell that it is achievable through the stride that he has made in the past.